These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 24794122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo evaluation of atherosclerotic plaque inflammation and of anti-inflammatory effects of statins by 18F-fluorodeoxyglucose positron emission tomography.
    Gerber BL.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):918-20. PubMed ID: 23727087
    [No Abstract] [Full Text] [Related]

  • 4. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
    Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083
    [Abstract] [Full Text] [Related]

  • 5. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K.
    Circ J; 2012 Sep 03; 76(4):809-11. PubMed ID: 22451448
    [No Abstract] [Full Text] [Related]

  • 6. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
    Kawahara T, Nishikawa M, Kawahara C, Inazu T, Sakai K, Suzuki G.
    Circulation; 2013 Jun 11; 127(23):2327-35. PubMed ID: 23658438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.
    Huang BT, Chen M.
    Diabetes Care; 2015 Feb 11; 38(2):e27. PubMed ID: 25614700
    [No Abstract] [Full Text] [Related]

  • 9. Response to Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.
    Stegman B, Puri R, Shao M, Nicholls SJ.
    Diabetes Care; 2015 Feb 11; 38(2):e28-9. PubMed ID: 25614701
    [No Abstract] [Full Text] [Related]

  • 10. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T, Ota H, Hasebe N.
    Nihon Rinsho; 2011 Nov 11; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Who benefits from statins? Patient or focal plaque?
    Fujii K, Masuyama T.
    Circ J; 2012 Nov 11; 76(12):2744-5. PubMed ID: 23117744
    [No Abstract] [Full Text] [Related]

  • 13. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month.
    Martín-Ventura JL, Blanco-Colio LM, Gómez-Hernández A, Muñoz-García B, Vega M, Serrano J, Ortega L, Hernández G, Tuñón J, Egido J.
    Stroke; 2005 Aug 11; 36(8):1796-800. PubMed ID: 16020773
    [Abstract] [Full Text] [Related]

  • 14. [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study].
    Miyauchi K.
    Nihon Rinsho; 2011 Nov 11; 69 Suppl 9():321-30. PubMed ID: 22724223
    [No Abstract] [Full Text] [Related]

  • 15. Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials.
    Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T.
    Int J Cardiol; 2012 Aug 09; 159(1):69-72. PubMed ID: 22575629
    [No Abstract] [Full Text] [Related]

  • 16. Statins for treating stable angina: can statins improve the plaque morphology and angina?
    Lee CW, Park SJ.
    Future Cardiol; 2013 Mar 09; 9(2):155-8. PubMed ID: 23463966
    [No Abstract] [Full Text] [Related]

  • 17. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX, Heng XH, Guo RW, Si YK, Qi F, Zhou XB.
    J Cardiovasc Pharmacol; 2013 Aug 09; 62(2):205-11. PubMed ID: 23615158
    [Abstract] [Full Text] [Related]

  • 18. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, Tanaka N, Nakaya K, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F.
    Eur J Cardiovasc Prev Rehabil; 2009 Apr 09; 16(2):222-8. PubMed ID: 19242355
    [Abstract] [Full Text] [Related]

  • 19. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
    Verhoeven BA, Moll FL, Koekkoek JA, van der Wal AC, de Kleijn DP, de Vries JP, Verheijen JH, Velema E, Busser E, Schoneveld A, Virmani R, Pasterkamp G.
    Stroke; 2006 Aug 09; 37(8):2054-60. PubMed ID: 16809559
    [Abstract] [Full Text] [Related]

  • 20. MR imaging-verified plaque delipidation with lipid-lowering therapy important questions remain.
    Kramer CM, Mani V, Fayad ZA.
    JACC Cardiovasc Imaging; 2011 Sep 09; 4(9):987-9. PubMed ID: 21920336
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.